• Skip to primary navigation
  • Skip to content
  • Skip to footer navigation
Aucta Pharma

Aucta Pharma

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
    • 简体中文
  • Investors
  • Press Release/News

Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership

Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application

Aucta Pharmaceuticals AnnouncesLicensing of Vigabatrin for Oral Solution in China

Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
Powered by Points Group • Privacy Policy •